As explained in Chapter 1, we have chosen to focus our international comparison mainly on
the area of biomedicine, defined broadly to include pharmaceuticals (not only those based …

The previous chapter discussed the divergent cluster performance in Ohio and Sweden as
perceived by the firms in these clusters. In this chapter we address the same questions from …

The Stockholm-Uppsala region is claimed to be one of the worlds' most expansive
biomedical regions, both when it concerns scientific and business activities. Or, as it was …

This chapter deals with the question raised in Chapter 4—namely,“Why has the biomedical
cluster in Ohio grown faster and become more fully developed than that in Sweden?” By …

This book presents the results of Cleverbio, a project funded by theEuropean Commission.
The project examined the process of growth anddevelopment of clusters in the biotech …

Since its origin, biotechnology has developed in few centres of excellence identifiable as
biotech clusters. Even if these usually present common features in terms of organisations …

This chapter examines the forces that sparked the emergence of a leading European
biotechnology cluster-Medicon Valley. This cluster displays one characteristic feature which …

Technological Systems in the Bio Industries: An International Study represents a
comprehensive, interdisciplinary, and systematic effort to understand the nature and role of …

Regional or local clusters of enterprises of a certain industry or value chain are increasingly
regarded as protagonists of economic growth. Developments like the emergence of Silicon …

Competitive advantage in the biotech industry depends on several key factors: the existence
of vibrant academic institutions (Kenney 1986), venture capital and other forms of risk …